Tenax Therapeutics (TENX) Enterprise Value (2010 - 2026)
Tenax Therapeutics (TENX) reported Enterprise Value of -$118.8 million for Q1 2026, down 6.56% on a YoY basis from -$127.1 million in Q1 2025, and down 21.72% sequentially from -$97.6 million in Q4 2025.
Tenax Therapeutics (TENX) Enterprise Value (2010 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 17 years of Enterprise Value data on file, last reported at -$118.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 6.56% year-over-year to -$118.8 million; the trailing twelve-month figure through Mar 2026 stood at -$118.8 million (down 6.56% YoY), and the FY2025 full-year result was -$97.6 million, down 2.86% from the prior year.
- Enterprise Value retreated to -$118.8 million in Q1 2026, from -$97.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.1 million in Q4 2022 to a low of -$118.8 million in Q1 2026.
- A 5-year average of -$47.8 million and a median of -$13.4 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 61.96% in 2022 and tumbled 1023.85% in 2025, its largest moves.
- Tracing TENX's Enterprise Value over 5 years: stood at -$2.1 million in 2022, then sank by 361.02% to -$9.8 million in 2023, then sank by 868.66% to -$94.9 million in 2024, then slipped by 2.86% to -$97.6 million in 2025, then fell by 21.72% to -$118.8 million in 2026.
- Business Quant data shows TENX's Enterprise Value at -$118.8 million in Q1 2026, -$97.6 million in Q4 2025, and -$99.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | -118.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.76 Mn |
| Dec 31, 2025 | -97.57 Mn |
| Sep 30, 2025 | -99.37 Mn |
| Jun 30, 2025 | -105.46 Mn |
| Mar 31, 2025 | -111.45 Mn |
| Dec 31, 2024 | -94.85 Mn |
| Sep 30, 2024 | -98.31 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Mar 31, 2024 | -12.55 Mn |
| Dec 31, 2023 | -9.79 Mn |
| Sep 30, 2023 | -11.14 Mn |
| Jun 30, 2023 | -13.39 Mn |
| Mar 31, 2023 | -14.41 Mn |
| Dec 31, 2022 | -2.12 Mn |
| Sep 30, 2022 | -3.81 Mn |
| Jun 30, 2022 | -7.23 Mn |
| Mar 31, 2022 | -2.87 Mn |
| Dec 31, 2021 | -5.58 Mn |
| Sep 30, 2021 | -8.35 Mn |
| Jun 30, 2021 | -2.18 Mn |